Fundamentals for Colgate-Palmolive Company
Recent trading of CL stock saw 12 sales, with market price at 92.30833371480306 per share.There were no sell transactions throughout the period under consideration....
Business Operations:
Sector: Consumer DefensiveIndustry: Household & Personal Products
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Revenue projections:
Financial Ratios:
| currentRatio | 0.95800 |
|---|---|
| forwardPE | 23.90133 |
| debtToEquity | 1205.62500 |
| earningsGrowth | 0.03300 |
| revenueGrowth | 0.04600 |
| grossMargins | 0.60644 |
| operatingMargins | 0.20662 |
| trailingEps | 2.57000 |
| forwardEps | 4.10019 |
CL's Forward PE is at a healthy level, meaning the stock price is aligned favorably with earnings. This suggests that the stock isn't overpriced, providing room for growth and making it an appealing option for investors looking to capitalize on potential future gains.
CL's high debt-to-equity ratio indicates that the company is using more debt than equity to fund its operations. This high leverage could expose the company to greater financial risk, especially during periods of declining profitability.
CL's positive gross and operating margins suggest the company is performing profitably. These margins reflect efficient cost management and strong revenue generation, signaling healthy financial performance and operational effectiveness.
With CL's forward EPS higher than its trailing EPS, the company is expected to be more profitable in the current financial year. This signals confidence in CL's growth potential, as improved earnings are forecasted compared to the prior year's performance.
Price projections:
Insider Transactions:
Recent trading of CL stock saw 12 sales, with market price at 92.30833371480306 per share.There were no sell transactions throughout the period under consideration.Investors are purchasing Colgate-Palmolive Company more frequently than selling it near the current price levels, which might point to a bullish sentiment. This pattern could be interpreted as a favorable outlook for the stock's future.
Recommendation changes over time:
Analysts' buy bias toward CL suggests the stock is seen as a solid investment, potentially motivating investors to consider it for their portfolios. With this positive outlook, CL is likely to be viewed as a secure place to allocate funds, driving further interest in the stock.